Clippert Medical Sales, Inc. v. Smith & Nephew Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Clippert Medical Sales, Inc. v. Smith & Nephew Inc.

Sort by

Viewing results 1‒25 of 58

AstraZeneca PLC
AstraZeneca chair says it is paying CEO enough to ward off US rivals
...In 2019, Namal Nawana, an Australian who had worked in the US, quit as chief executive of Smith & Nephew because the UK medical devices company could not meet his pay demands....
May 4, 2023
Smith & Nephew PLC
Smith & Nephew in talks to buy NuVasive for over $3bn
...Smith & Nephew has held talks to buy NuVasive, a maker of medical instruments used in spinal surgery, in a deal that would be worth more than $3bn and mark the largest acquisition by the British medical...
February 8, 2019
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
City Bulletin
Opening Quote: ITV cuts costs as ad revenues collapse
...FTSE 100 group Smith & Nephew had an even worse April than ITV. April revenues for the medical devices maker dropped 47 per cent, as elective surgeries have come to a halt in many countries....
May 6, 2020
FT SeriesCompanies prospering in the pandemic
Pharma industry seizes on pandemic as a shot at redemption
...The lockdowns imposed to contain the virus are likely to have hit sales of drugs that need a doctor to administer them, while the delay in non-essential surgeries has hurt others including Smith & Nephew...
July 6, 2020
Due Diligence
Morgan Stanley tests M&A waters with millennial millionaires play Premium content
...The boss at Smith & Nephew, the UK-listed medical devices group, told the market that he was hunting for deals and that he had the firepower to deliver them. DD took his word....
February 12, 2019
US & Canadian companies
Burberry spurned takeover approaches from bigger US rival Coach
...Its finance director Carol Fairweather was also replaced by Julie Brown, who joined from Smith & Nephew, the UK medical device company....
December 4, 2016
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
fastFT
Smith & Nephew to launch $300m share buy-back
...Medical devices maker Smith & Nephew is planning to return $300m to shareholders through a share buyback, after agreeing to sell its gynaecology business to rival equipment maker, Medtronic....
May 18, 2016
InterviewEuropean companies
Olivier Bohuon insists Smith & Nephew can prosper on its own
...Is Smith & Nephew the one that got away? The UK medical device maker has long been seen as a potential target for bigger US rivals....
October 11, 2015
US & Canadian companies
Smith & Nephew dismisses fears of threat from consolidated rivals
...The Biomet deal would make Zimmer the second-ranking orthopaedics company by sales, behind Johnson & Johnson. Smith & Nephew would be fourth, behind Stryker....
May 1, 2014
European equities
Bid moves boost European stock markets
...Fellow drugmaker Shire was up 3 per cent at £32.05, while GlaxoSmithKline added 1.1 per cent at £16.71 and medical devices maker Smith & Nephew gained 1 per cent to 924p....
April 28, 2014
US & Canadian companies
AbbVie set to unveil £31bn Shire takeover
...However, the loss of the third-biggest UK-listed drugmaker after AstraZeneca and GlaxoSmithKline would increase the sense of siege surrounding FTSE 100 healthcare companies, with Smith & Nephew, the medical...
July 17, 2014
US & Canadian companies
AbbVie rounds on US tax laws as it snares Shire
...Even so, the loss of the third-biggest UK-listed drugmaker after AstraZeneca and GlaxoSmithKline is likely to increase the sense of siege surrounding FTSE 100 healthcare companies, with Smith & Nephew, the...
July 18, 2014
US & Canadian companies
Shire shores up defences against AbbVie
...The UK-listed drugmaker is the third FTSE 100 healthcare company to be targeted by a US rival so far this year after AstraZeneca fought off Pfizer and Smith & Nephew attracted tentative interest from Stryker...
June 22, 2014
US & Canadian companies
Medical taxes: own devices
...Most of the big device companies – Medtronic, Stryker, Boston Scientific, Zimmer, Smith & Nephew – have underperformed the market since Mr Obama’s inauguration....
October 1, 2013
US & Canadian companies
Private equity groups weigh Biomet exit
...Blackstone, KKR, Goldman Sachs’s private equity unit and TPG Capital will also consider a complete sale of the Warsaw, Indiana-based medical device maker in a so-called dual track, as they seek to maximise...
July 1, 2013
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
US financial regulation
Smith & Nephew in $22m bribes fine
...Olivier Bohuon, Smith & Nephew’s chief executive, said: “These legacy issues do not reflect Smith & Nephew today....
February 6, 2012
US & Canadian companies
DoJ fines Biomet $23m over bribery
...Johnson & Johnson settled one such case last year and Smith & Nephew was fined earlier this year....
March 26, 2012
Oil
Tullow Oil underperforms over Ghana fears
...Implant maker Smith & Nephew fell 1.2 per cent to 618p after a British Medical Journal study raised concerns about failing metal-on-metal hip replacements....
February 28, 2012
LexUK companies
Medical Devices
...Jude, Boston Scientific) underperforming badly while orthopaedic specialists (Stryker, Smith & Nephew, and Zimmer) have fared better....
July 18, 2011
Healthcare
Kinetic Concepts
...Smith & Nephew introduced the first big competitor two and a half years ago, yet Kinetic’s revenues have remained stable....
July 13, 2011
Companies By Region
Smith & Nephew chief eyes expansion
...The new chief executive of Smith & Nephew brushed off suggestions that the company needed a bigger partner as he pledged to lay out a new strategy by early August for the UK-based medical device company....
May 5, 2011
FT AlphavilleNeil Hume
Bid hopes fade for Smith & Nephew
...It’s Smith & Nephew, which has slipped 4 per cent after it emerged that Johnson & Johnson wants put its $28bn cash pile to work in Switzerland by acquiring a medical devices company called Synthes....
April 18, 2011
US & Canadian companies
J&J leaps amid Swiss talks reports
...Earlier this year the company made an unsuccessful bid for Smith & Nephew, a UK hip and knee replacement company that was said to be valued at nearly $11bn....
April 15, 2011
Pharmaceuticals sector
Synthes confirms discussions with J&J
...J&J earlier this year made an unsuccessful bid for Smith & Nephew, the UK hip and knee replacement company that was said to be valued at nearly $11bn....
April 18, 2011
FT AlphavilleNeil Hume
Fair disclosure – UK takeover edition
...An indicative offer valuing Smith & Nephew (S&N), one of the world’s largest orthopaedics-makers, at more than 750p-a-share was tabled with the company several weeks before Christmas, I’m told....
January 9, 2011

Previous pagePage 1 of 3Next page